CARL · CARLSMED INC
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Market Cap
474.1M
52 Wk Range
$8.50 - $19.15
Previous Close
$17.30
Open
$17.63
Volume
219,687
Day Range
$16.60 - $17.70
Enterprise Value
451.3M
Cash
80.21M
Avg Qtr Burn
-8.674M
Insider Ownership
43.27%
Institutional Own.
40.91%
Qtr Updated
Sep 30th 2026
